Advertisement

International Journal of Clinical Pharmacy

, Volume 36, Issue 5, pp 1014–1022 | Cite as

Exploring the implementation of a medication adherence programme by community pharmacists: a qualitative study

  • Julien Marquis
  • Marie P. Schneider
  • Brenda Spencer
  • Olivier Bugnon
  • Sophie Du PasquierEmail author
Research Article

Abstract

Background Medication adherence has been identified as an important factor for clinical success. Twenty-four Swiss community pharmacists participated in the implementation of an adherence support programme for patients with hypertension, diabetes mellitus and/or dyslipidemia. The programme combined tailored consultations with patients about medication taking (expected at an average of one intervention per month) and the delivery of each drug in an electronic monitoring system (MEMS6™). Objective To explore pharmacists’ perceptions and experiences with implementation of the medication adherence programme and to clarify why only seven patients were enrolled in total. Setting Community pharmacies in French-speaking Switzerland. Method Individual in-depth interviews were audio-recorded, with 20 of the pharmacists who participated in the adherence programme. These were transcribed verbatim, coded and thematically analysed. Process quality was ensured by using an audit trail detailing the development of codes and themes; furthermore, each step in the coding and analysis was verified by a second, experienced qualitative researcher. Main outcome measure Community pharmacists’ experiences and perceptions of the determining factors influencing the implementation of the adherence programme. Results Four major barriers were identified: (1) poor communication with patients resulting in insufficient promotion of the programme; (2) insufficient collaboration with physicians; (3) difficulty in integrating the programme into pharmacy organisation; and (4) insufficient pharmacist motivation. This was related to the remuneration perceived as insufficient and to the absence of clear strategic thinking about the pharmacist position in the health care system. One major facilitator of the programme’s implementation was pre-existing collaboration with physicians. Conclusion A wide range of barriers was identified. The implementation of medication adherence programmes in Swiss community pharmacies would benefit from an extended training aimed at developing communication and change management skills. Individualised onsite support addressing relevant barriers would also be necessary throughout the implementation process.

Keywords

Cognitive pharmaceutical services Community pharmacy Interdisciplinary collaboration Implementation Medication adherence Pharmacists Qualitative research Switzerland 

Notes

Acknowledgments

We wish to thank all the pharmacists who granted interviews and/or participated in the NARC study. We also wish to thank Alison Roberts for her contribution to the design of the interview guide.

Funding

This study was funded by the Department of Ambulatory Care and Community Medicine, University of Lausanne, Switzerland.

Conflicts of interest

The authors have no conflicts of interest to declare.

References

  1. 1.
    Sabate E. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization. 2003. ISBN: 92-4-15499-2.Google Scholar
  2. 2.
    Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005;43(6):521–30.PubMedCrossRefGoogle Scholar
  3. 3.
    Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–97.PubMedCrossRefGoogle Scholar
  4. 4.
    WHO Expert Committee on specifications for pharmaceutical preparations. Annex 8: good pharmacy practice—joint FIP/WHO guidelines on GPP. Standards for quality of pharmacy services. 2011. http://whqlibdoc.who.int/trs/WHO_TRS_961_eng.pdf.
  5. 5.
    Schneider MP, Aslani P. Adherence policy, education and practice: an international perspective. Pharm Pract (Internet). 2010;8(4):209–12.Google Scholar
  6. 6.
    Krummenacher I, Cavassini M, Bugnon O, Schneider MP. An interdisciplinary HIV-adherence program combining motivational interviewing and electronic antiretroviral drug monitoring. AIDS Care. 2011;23(5):550–61.PubMedCrossRefGoogle Scholar
  7. 7.
    Krummenacher I, Cavassini M, Bugnon O, Spirig R, Schneider MP, Swiss HIVCS. Antiretroviral adherence program in HIV patients: a feasibility study in the Swiss HIV Cohort Study. Pharm World Sci. 2010;32(6):776–86.PubMedCrossRefGoogle Scholar
  8. 8.
    Guignard E, Bugnon O. Pharmaceutical care in community pharmacies: practice and research in Switzerland. Ann Pharmacother. 2006;40(3):512–7.PubMedCrossRefGoogle Scholar
  9. 9.
    pharmaSuisse. Convention tarifaire (RBP IV). 2009. [cited 2014 march 13]. http://www.pharmasuisse.org/data/Oeffentlich/fr/Themen/LOA_IV_Tarifvertrag_f.pdf.
  10. 10.
    Roberts AS, Benrimoj SI, Chen TF, Williams KA, Aslani P. Implementing cognitive services in community pharmacy: a review of facilitators used in practice change. Int J Pharm Pract. 2006;14(3):163–70.CrossRefGoogle Scholar
  11. 11.
    Gastelurrutia MA, Benrimoj SI, Castrillon CC, de Amezua MJ, Fernandez-Llimos F, Faus MJ. Facilitators for practice change in Spanish community pharmacy. Pharm World Sci. 2009;31(1):32–9.PubMedCrossRefGoogle Scholar
  12. 12.
    Roberts AS, Hopp T, Sorensen EW, Benrimoj SI, Chen TF, Herborg H, et al. Understanding practice change in community pharmacy: a qualitative research instrument based on organisational theory. Pharm World Sci. 2003;25(5):227–34.PubMedCrossRefGoogle Scholar
  13. 13.
    Miles MB, Huberman AM. Qualitative data analysis : an expanded sourcebook. 2nd ed. Thousand Oaks: Sage Publications; 1994. ISBN 0-8039-5540-5.Google Scholar
  14. 14.
    Pope C, Ziebland S, Mays N. Analysing qualitative data. In: Pope C, Mays N, editors. Qualitative research in health care. 3rd ed. Malden: Blackwell Publishing; 2006. p. 63–81.CrossRefGoogle Scholar
  15. 15.
    Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15(9):1277–88.PubMedCrossRefGoogle Scholar
  16. 16.
    Ray D, Schwingruber K. Étude permanente des coûts en pharmacie. Pharma J. 2009;13:35–6.Google Scholar
  17. 17.
    Schneider MP, Krummenacher I, Figueiredo H, Marquis J, Bugnon O. Adherence: a review of education, research, practice and policy in Switzerland. Pharm Pract. 2009;7(2):63–73.Google Scholar
  18. 18.
    Emmerton LM, Smith L, LeMay KS, Krass I, Saini B, Bosnic-Anticevich SZ, et al. Experiences of community pharmacists involved in the delivery of a specialist asthma service in Australia. BMC Health Serv Res. 2012;12:164.PubMedCrossRefPubMedCentralGoogle Scholar
  19. 19.
    Murphy AL, MacKinnon NJ, Flanagan PS, Bowles SK, Sketris IS. Pharmacists’ participation in an inhaled respiratory medication program: reimbursement of professional fees. Ann Pharmacother. 2005;39(4):655–61.PubMedCrossRefGoogle Scholar
  20. 20.
    Chui MA, Mott DA, Maxwell L. A qualitative assessment of a community pharmacy cognitive pharmaceutical services program, using a work system approach. Res Soc Adm Pharm. 2012;8(3):206–16.CrossRefGoogle Scholar
  21. 21.
    Kaae S, Norgaard LS. How to engage experienced medicine users at the counter for a pharmacy-based asthma inhaler service. Int J Pharm Pract. 2012;20(2):99–106.PubMedCrossRefGoogle Scholar
  22. 22.
    Niquille A, Lattmann C, Bugnon O. Medication reviews led by community pharmacists in Switzerland: a qualitative survey to evaluate barriers and facilitators. Pharm Pract. 2010;8(1):35–42.Google Scholar
  23. 23.
    Hughes CM, McCann S. Perceived interprofessional barriers between community pharmacists and general practitioners: a qualitative assessment. Br J Gen Pract. 2003;53(493):600–6.PubMedPubMedCentralGoogle Scholar
  24. 24.
    Roberts AS, Benrimoj SI, Chen TF, Williams KA, Aslani P. Practice change in community pharmacy: quantification of facilitators. Ann Pharmacother. 2008;42(6):861–8.PubMedCrossRefGoogle Scholar
  25. 25.
    Barnes JM, Riedlinger JE, McCloskey WW, Montagne M. Barriers to compliance with OBRA’90 regulations in community pharmacies. Ann Pharmacother. 1996;30(10):1101–5.PubMedGoogle Scholar
  26. 26.
    Kroger E, Moisan J, Gregoire JP. Billing for cognitive services: understanding Quebec pharmacists’ behavior. Ann Pharmacother. 2000;34(3):309–16.PubMedCrossRefGoogle Scholar
  27. 27.
    Lowrie R, Johansson L, Forsyth P, Bryce SL, McKellar S, Fitzgerald N. Experiences of a community pharmacy service to support adherence and self-management in chronic heart failure. Int J Clin Pharm. 2014;36(1):154–62.PubMedCrossRefGoogle Scholar
  28. 28.
    Niquille A, Ruggli M, Buchmann M, Jordan D, Bugnon O. The nine-year sustained cost-containment impact of swiss pilot physicians–pharmacists quality circles. Ann Pharmacother. 2010;44(4):650–7.PubMedCrossRefGoogle Scholar
  29. 29.
    Carter BL, van Mil JW. Comparative effectiveness research: evaluating pharmacist interventions and strategies to improve medication adherence. Am J Hypertens. 2010;23(9):949–55.PubMedCrossRefGoogle Scholar
  30. 30.
    Rogers EM. Diffusion of innovations. 5th ed. New York: Free Press; 2003. ISBN 0-7432-2209-1.Google Scholar
  31. 31.
    Rabin BA, Brownson RC, Haire-Joshu D, Kreuter MW, Weaver NL. A glossary for dissemination and implementation research in health. J Public Health Manag Pract. 2008;14(2):117–23.PubMedCrossRefGoogle Scholar
  32. 32.
    Roberts AS, Benrimoj SI, Chen TF, Williams KA, Hopp TR, Aslani P. Understanding practice change in community pharmacy: a qualitative study in Australia. Res Soc Adm Pharm. 2005;1(4):546–64.CrossRefGoogle Scholar
  33. 33.
    Feletto E, Wilson LK, Roberts AS, Benrimoj SI. Flexibility in community pharmacy: a qualitative study of business models and cognitive services. Pharm World Sci. 2010;32(2):130–8.PubMedCrossRefGoogle Scholar
  34. 34.
    Kaae S, Sondergaard B, Haugbolle LS, Traulsen JM. The relationship between leadership style and provision of the first Danish publicly reimbursed cognitive pharmaceutical service—a qualitative multicase study. Res Soc Adm Pharm. 2011;7(2):113–21.CrossRefGoogle Scholar
  35. 35.
    Hopp TR, Sorensen EW, Herborg H, Roberts AS. Implementation of cognitive pharmaceutical services (CPS) in professionally active pharmacies. Int J Pharm Pract. 2005;13(1):21–31.CrossRefGoogle Scholar
  36. 36.
    van de Steeg-van Gompel C, Wensing M, De Smet PAGM. Implementation of adherence support for patients with hypertension despite antihypertensive therapy in general practice: a cluster randomized trial. Am J Hypertens. 2010;23(9):1038–45.PubMedCrossRefGoogle Scholar
  37. 37.
    Dualde E, Faus MJ, Santonja FJ, Fernandez-Llimos F. Effectiveness of a videoconference training course on implementing pharmacy services. Pharm World Sci. 2009;31(6):638–42.PubMedCrossRefGoogle Scholar
  38. 38.
    Holdford DA. Leadership theories and their lessons for pharmacists. Am J Health Syst Pharm. 2003;60(17):1780–6.PubMedGoogle Scholar
  39. 39.
    Peters DH, Adam T, Alonge O, Agyepong IA, Tran N. Implementation research: what it is and how to do it. BMJ. 2013;347:f6753.PubMedCrossRefGoogle Scholar
  40. 40.
    Stetler CB, Legro MW, Wallace CM, Bowman C, Guihan M, Hagedorn H, et al. The role of formative evaluation in implementation research and the QUERY experience. J Gen Intern Med. 2006;21(Suppl 2):S1–8.PubMedCrossRefPubMedCentralGoogle Scholar
  41. 41.
    Curran GM, Bauer M, Mittman B, Pyne JM, Stetler C. Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact. Med Care. 2012;50(3):217–26.PubMedCrossRefPubMedCentralGoogle Scholar

Copyright information

© Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie 2014

Authors and Affiliations

  • Julien Marquis
    • 1
    • 2
  • Marie P. Schneider
    • 1
    • 2
  • Brenda Spencer
    • 3
  • Olivier Bugnon
    • 1
    • 2
  • Sophie Du Pasquier
    • 2
    • 4
    Email author
  1. 1.Community Pharmacy, School of Pharmaceutical SciencesUniversity of Geneva, University of LausanneGenevaSwitzerland
  2. 2.Community Pharmacy, Department of Ambulatory Care and Community MedicineUniversity of LausanneLausanneSwitzerland
  3. 3.Institute of Social and Preventive Medicine (IUMSP), Lausanne University HospitalLausanneSwitzerland
  4. 4.Community Pharmacy, Pharmacie de la Policlinique Médicale UniversitaireLausanneSwitzerland

Personalised recommendations